NW Roselle in Grade 1 Essential Hypertension: Phase III Clinical Trial

PHASE3Not yet recruitingINTERVENTIONAL

Enrollment

286

Participants

Timeline

Start Date

March 31, 2024

Primary Completion Date

April 30, 2025

Study Completion Date

April 30, 2025

Conditions

Essential Hypertension

Interventions

DRUG

NW Roselle

NW Roselle is a powdered extract from the flowers of Hibiscus Sabdariffa (300mg) and the leaves of Olea europaea (200 mg).

DRUG

Captopril 25Mg Tab

Active Comparator

All Listed Sponsors

lead

Natural Wellness Egypt

INDUSTRY

NCT06141200 - NW Roselle in Grade 1 Essential Hypertension: Phase III Clinical Trial | Biotech Hunter | Biotech Hunter